Godin D V, Tuchek J M
Br J Pharmacol. 1983 Jun;79(2):421-8. doi: 10.1111/j.1476-5381.1983.tb11015.x.
The ability of chemically detoxified E. coli endotoxins and membrane-active agents to modify the toxicity of native E. coli endotoxin in vivo was examined. The time- and dose-dependent increase in plasma acid phosphatase activity following toxin administration to rats provided a convenient quantitative measure of in vivo toxicity under various experimental conditions. Treatment of endotoxin with either sodium hydroxide or sodium periodate produced substances which, when injected alone, failed to cause an increase in plasma acid phosphatase activity. When given before native endotoxin, periodate-detoxified toxin produced a dose-dependent reduction in the elevation of plasma enzyme activity caused by unmodified toxin. Pretreatment with pranolium, hydrocortisone or (+)-propranolol also reduced the in vivo toxicity of endotoxin. Mortality studies in mice provided further independent support for the effectiveness of periodate-detoxified endotoxin and membrane-active drugs as endotoxin antagonists. Evidence has been found that under certain conditions gentamicin may act synergistically with bacterial endotoxins in vivo.
研究了化学解毒的大肠杆菌内毒素和膜活性剂在体内改变天然大肠杆菌内毒素毒性的能力。给大鼠注射毒素后,血浆酸性磷酸酶活性随时间和剂量的增加,为各种实验条件下的体内毒性提供了一种方便的定量测量方法。用氢氧化钠或高碘酸钠处理内毒素产生的物质,单独注射时不会导致血浆酸性磷酸酶活性增加。当在天然内毒素之前给予时,高碘酸盐解毒的毒素会使未修饰毒素引起的血浆酶活性升高呈剂量依赖性降低。用普萘洛尔、氢化可的松或(+)-普萘洛尔预处理也会降低内毒素的体内毒性。小鼠死亡率研究为高碘酸盐解毒内毒素和膜活性药物作为内毒素拮抗剂的有效性提供了进一步的独立支持。已发现证据表明,在某些条件下庆大霉素可能在体内与细菌内毒素协同作用。